Brinks DEA Compliance Consulting Services
Brinks DEA Consulting provides strategic, compliance-driven guidance to organizations navigating the complexities of the Controlled Substances Act (CSA) and DEA regulations. Founded by Scott A. Brinks—former DEA Section Chief and nationally recognized authority in diversion control and regulatory policy—the firm delivers practical, real-world solutions grounded in decades of federal enforcement and regulatory leadership. Our services are designed to help healthcare providers, pharmaceutical manufacturers, distributors, and legal teams reduce risk, strengthen compliance programs, and confidently prepare for DEA scrutiny.
Our Services
- Regulatory Strategy & Drafting
- Expert analysis of DEA regulations and CSA compliance consulting
- Development of internal policies aligned with federal rulemaking
- Support for Notices of Proposed Rulemaking (NPRMs) and Final Rules
- Assistance with preparing public comments on DEA rulemakings
- Analysis of public comments during the rulemaking process
- DEA Compliance Consulting Audits & Readiness
- Mock DEA inspections and audit preparation
- DEA registration support and binder compilation
- Controlled substance record reviews and accountability audits
- Development and refinement of Standard Operating Procedures (SOPs)
- Risk Assessment & Investigative Support
- “Red flag” analysis of prescribing and dispensing data
- Suspicious Order Monitoring (SOM) system evaluations
- Due diligence and internal compliance investigations
- Education & Training
- Customized training for DEA registrants and compliance teams
- CSA and DEA regulatory workshops (live or virtual)
- Train-the-trainer programs for internal compliance leadership
- Post‑Litigation Consulting
- Forensic review of compliance failures
- Policy remediation and corrective action planning
- Expert witness services in DEA-related litigation